Abstract
Patients with established coronary artery disease remain at elevated risk of major adverse cardiac events. The goal of this study was to evaluate the utility of plasminogen activator inhibitor-1-positive platelet-derived extracellular vesicles as a biomarker for major adverse cardiac events and to explore potential underlying mechanisms. Our study suggests these extracellular vesicles as a potential biomarker to identify and a therapeutic target to ameliorate neointimal formation of high-risk patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 985-997 |
| Number of pages | 13 |
| Journal | JACC: Basic to Translational Science |
| Volume | 7 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 2022 |
Fingerprint
Dive into the research topics of 'Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS